Schreiner ProTech today announced it is applying a revolutionary laser technology-based manufacturing process to the production of automotive airbag wraps, improving airbag reliability and production efficiency.
The Department of Computing and Electronic Systems at the University of Essex has received over £120,000 for a prestigious EU Marie Curie Fellowship.
A new EU-funded project to boost the capacity and efficiency of the next generation of optical networks has just got underway. The PHASORS ('Phase sensitive amplifier systems and optical regenerators and their applications') initiative is funded under the 'Information and communication technology' (ICT) Theme of the Seventh Framework Programme (FP7) to the tune of EUR 3.9 million.
The PRIMA instrument of the ESO Very Large Telescope Interferometer (VLTI) recently saw "first light" at its new home atop Cerro Paranal in Chile. When fully operational, PRIMA will boost the capabilities of the VLTI to see sources much fainter than any previous interferometers, and enable astrometric precision unmatched by any other existing astronomical facility.
SOLX, Inc. announced today U.S. Food and Drug (FDA) 510(k) clearance for the SOLX 790 to perform Titanium:Sapphire laser trabeculoplasty (TLT). The 510(k) clearance was based on the results of a multi-center, international clinical trial that established equivalency of TLT to ALT in the ability to reduce intraocular pressure (IOP) in patients having primary open angle glaucoma and poorly controlled IOP on maximally tolerated medications and/or prior failed trabeculoplasty. The laser had previously been approved for sale in Europe and Canada.
Samuel Krinsky, a physicist at the U.S. Department of Energy's Brookhaven National Laboratory, has won thee 2008 Free Electron Laser (FEL) Prize. Sponsored by the FEL Conference, which was held this year in Gyeungju, Korea, the prize consists of an award citation, a plaque, and approximately $3,000.
A new advance in cellular imaging is allowing scientists to better understand the movement of cells in the area around tumors, also known as the tumor microenvironment. In a recent article published in Disease Models + Mechanisms (DMM), dmm.biologists.org, Zena Werb and colleagues used optimized methods of laser microscopy to track the movement of live cells in a mouse model of breast cancer.
Luxtera, the worldwide leader in Silicon CMOS Photonics, today announced that the German private foundation Berthold Leibinger Stiftung awarded L. Cary Gunn, co-founder and chief technology officer for Luxtera, with the international prize Berthold Leibinger Innovationspreis. The jury selected Gunn for his innovative work in the development of laser technology with specific advancements in Silicon CMOS Photonics.
In a quest to push the limits of intensity to achieve extreme light-matter interactions in large molecules, a team of researchers from RIKEN's Advanced Science Institute in Wako, the SPring-8 Center in Harima, and the University of Tokyo, has demonstrated the ionisation and consequently the dissociation of nitrogen molecules using a free-electron laser.
PathoLase, Inc., an emerging leader in the medical technology industry, reported today that a select group of leading podiatrists in several markets in the US are now treating patients who suffer from toenail fungus (Onychomycosis) with its ground breaking laser technology. Using PathoLase's patented PinPointe FootLaser system, podiatrists in Sacramento, San Jose, Salt Lake City and Belleville, New Jersey are open for business treating their patients' toenail fungus.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.